123 related articles for article (PubMed ID: 27405093)
1. Identification of New Resistance Mechanisms in Escherichia coli against Apidaecin 1b Using Quantitative Gel- and LC-MS-Based Proteomics.
Schmidt R; Krizsan A; Volke D; Knappe D; Hoffmann R
J Proteome Res; 2016 Aug; 15(8):2607-17. PubMed ID: 27405093
[TBL] [Abstract][Full Text] [Related]
2. Influence of the yjiL-mdtM Gene Cluster on the Antibacterial Activity of Proline-Rich Antimicrobial Peptides Overcoming Escherichia coli Resistance Induced by the Missing SbmA Transporter System.
Krizsan A; Knappe D; Hoffmann R
Antimicrob Agents Chemother; 2015 Oct; 59(10):5992-8. PubMed ID: 26169420
[TBL] [Abstract][Full Text] [Related]
3. Identification of Api88 Binding Partners in Escherichia coli Using a Photoaffinity-Cross-Link Strategy and Label-Free Quantification.
Volke D; Krizsan A; Berthold N; Knappe D; Hoffmann R
J Proteome Res; 2015 Aug; 14(8):3274-83. PubMed ID: 26196380
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid composition of the outer membrane of Escherichia coli influences its susceptibility against antimicrobial peptide apidaecin 1b.
Schmidt R; Yonghong D; Hoffmann R
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):316-323. PubMed ID: 29329756
[TBL] [Abstract][Full Text] [Related]
5. Cellular uptake of apidaecin 1b and related analogs in Gram-negative bacteria reveals novel antibacterial mechanism for proline-rich antimicrobial peptides.
Berthold N; Hoffmann R
Protein Pept Lett; 2014 Apr; 21(4):391-8. PubMed ID: 24164266
[TBL] [Abstract][Full Text] [Related]
6. Correlating uptake and activity of proline-rich antimicrobial peptides in Escherichia coli.
Holfeld L; Hoffmann R; Knappe D
Anal Bioanal Chem; 2017 Sep; 409(23):5581-5592. PubMed ID: 28717895
[TBL] [Abstract][Full Text] [Related]
7. Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.
Berthold N; Czihal P; Fritsche S; Sauer U; Schiffer G; Knappe D; Alber G; Hoffmann R
Antimicrob Agents Chemother; 2013 Jan; 57(1):402-9. PubMed ID: 23114765
[TBL] [Abstract][Full Text] [Related]
8. Ribosomal binding and antibacterial activity of ethylene glycol-bridged apidaecin Api137 and oncocin Onc112 conjugates.
Goldbach T; Knappe D; Reinsdorf C; Berg T; Hoffmann R
J Pept Sci; 2016 Sep; 22(9):592-9. PubMed ID: 27406684
[TBL] [Abstract][Full Text] [Related]
9. Identification and elucidation of proline-rich antimicrobial peptides with enhanced potency and delivery.
Lai PK; Tresnak DT; Hackel BJ
Biotechnol Bioeng; 2019 Oct; 116(10):2439-2450. PubMed ID: 31209863
[TBL] [Abstract][Full Text] [Related]
10. Quantitative proteome analysis of an antibiotic resistant Escherichia coli exposed to tetracycline reveals multiple affected metabolic and peptidoglycan processes.
Jones-Dias D; Carvalho AS; Moura IB; Manageiro V; Igrejas G; Caniça M; Matthiesen R
J Proteomics; 2017 Mar; 156():20-28. PubMed ID: 28043878
[TBL] [Abstract][Full Text] [Related]
11. iTRAQ-coupled 2-D LC-MS/MS analysis of cytoplasmic protein profile in Escherichia coli incubated with apidaecin IB.
Zhou Y; Chen WN
J Proteomics; 2011 Dec; 75(2):511-6. PubMed ID: 21889622
[TBL] [Abstract][Full Text] [Related]
12. Effect of antimicrobial peptides from Apis mellifera hemolymph and its optimized version Api88 on biological activities of human monocytes and mast cells.
Keitel U; Schilling E; Knappe D; Al-Mekhlafi M; Petersen F; Hoffmann R; Hauschildt S
Innate Immun; 2013; 19(4):355-67. PubMed ID: 23112010
[TBL] [Abstract][Full Text] [Related]
13. iTRAQ-coupled 2-D LC-MS/MS analysis of membrane protein profile in Escherichia coli incubated with apidaecin IB.
Zhou Y; Chen WN
PLoS One; 2011; 6(6):e20442. PubMed ID: 21673808
[TBL] [Abstract][Full Text] [Related]
14.
Schmidt R; Knappe D; Wende E; Ostorházi E; Hoffmann R
Front Chem; 2017; 5():15. PubMed ID: 28373972
[TBL] [Abstract][Full Text] [Related]
15. Nisin-controlled extracellular production of apidaecin in Lactococcus lactis.
Zhou XX; Wang YB; Pan YJ; Li WF
Appl Microbiol Biotechnol; 2008 Apr; 78(6):947-53. PubMed ID: 18286279
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomics to evaluate multi drug resistance in Escherichia coli.
Piras C; Soggiu A; Bonizzi L; Gaviraghi A; Deriu F; De Martino L; Iovane G; Amoresano A; Roncada P
Mol Biosyst; 2012 Apr; 8(4):1060-7. PubMed ID: 22120138
[TBL] [Abstract][Full Text] [Related]
17. Investigating specific bacterial resistance to AMPs by using a magainin I-resistant Escherichia coli model.
de Almeida KC; Lima TB; Motta DO; Silva ON; Magalhães BS; Dias SC; Franco OL
J Antibiot (Tokyo); 2014 Oct; 67(10):681-7. PubMed ID: 24802209
[TBL] [Abstract][Full Text] [Related]
18. A sensitive quantification of the peptide apidaecin 1 isoforms in single bee tissues using a weak cation exchange pre-separation and nanocapillary liquid chromatography coupled with mass spectrometry.
Danihlík J; Šebela M; Petřivalský M; Lenobel R
J Chromatogr A; 2014 Dec; 1374():134-144. PubMed ID: 25435459
[TBL] [Abstract][Full Text] [Related]
19. In vivo target exploration of apidaecin based on Acquired Resistance induced by Gene Overexpression (ARGO assay).
Matsumoto K; Yamazaki K; Kawakami S; Miyoshi D; Ooi T; Hashimoto S; Taguchi S
Sci Rep; 2017 Sep; 7(1):12136. PubMed ID: 28939819
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship study using peptide arrays to optimize Api137 for an increased antimicrobial activity against Pseudomonas aeruginosa.
Bluhm ME; Knappe D; Hoffmann R
Eur J Med Chem; 2015 Oct; 103():574-82. PubMed ID: 26408816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
